XML 57 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Revenues $ 101,657 $ 135,737
Cost of products sold 72,927 101,546
Gross profit 28,730 34,191
Operating expenses:    
Research and development (including $ 260 and $313 of amortization of intangible assets, respectively) 7,216 8,593
Selling, general, and administrative (including $237 and $314 of amortization of intangible assets, respectively) 21,628 23,186
Total operating expenses 28,844 31,779
Operating income (loss) (114) 2,412
Other income (expense):    
Interest income 4 5
Interest expense (440) (559)
Miscellaneous (24) 171
Income (loss) from continuing operations before income taxes (574) 2,029
Income tax provision (benefit) - current 539 32
Income tax provision - deferred 15 448
Total income taxes provision (benefit) 554 480
Net income (loss) from continuing operations (1,128) 1,549
Discontinued operations:    
Loss from discontinued operations, net of tax (501) (3,687)
Net income (loss) (1,629) (2,138)
Net (income) loss attributable to noncontrolling interest 31 58
Net income (loss) attributable to Ultralife (1,598) (2,080)
Other comprehensive income (loss):    
Foreign currency translation adjustments 365 277
Comprehensive income (loss) attributable to Ultralife $ (1,233) $ (1,803)
Net income (loss) attributable to Ultralife common shareholders - basic    
Continuing operations (in Dollars per share) $ (0.06) $ 0.09
Discontinued operations (in Dollars per share) $ (0.03) $ (0.21)
Total (in Dollars per share) $ (0.09) $ (0.12)
Net income (loss) attributable to Ultralife common shareholders - diluted    
Continuing operations (in Dollars per share) $ (0.06) $ 0.09
Discontinued operations (in Dollars per share) $ (0.03) $ (0.21)
Total (in Dollars per share) $ (0.09) $ (0.12)
Weighted average shares outstanding - basic (in Shares) 17,403 17,304
Weighted average shares outstanding - diluted (in Shares) 17,403 17,336